BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17332290)

  • 1. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.
    Worley LA; Onken MD; Person E; Robirds D; Branson J; Char DH; Perry A; Harbour JW
    Clin Cancer Res; 2007 Mar; 13(5):1466-71. PubMed ID: 17332290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma.
    Onken MD; Worley LA; Person E; Char DH; Bowcock AM; Harbour JW
    Clin Cancer Res; 2007 May; 13(10):2923-7. PubMed ID: 17504992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma.
    Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ
    Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.
    Cassoux N; Rodrigues MJ; Plancher C; Asselain B; Levy-Gabriel C; Lumbroso-Le Rouic L; Piperno-Neumann S; Dendale R; Sastre X; Desjardins L; Couturier J
    Br J Ophthalmol; 2014 Jun; 98(6):769-74. PubMed ID: 24169649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies.
    Maat W; Jordanova ES; van Zelderen-Bhola SL; Barthen ER; Wessels HW; Schalij-Delfos NE; Jager MJ
    Arch Pathol Lab Med; 2007 Jan; 131(1):91-6. PubMed ID: 17227129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.
    Onken MD; Worley LA; Char DH; Augsburger JJ; Correa ZM; Nudleman E; Aaberg TM; Altaweel MM; Bardenstein DS; Finger PT; Gallie BL; Harocopos GJ; Hovland PG; McGowan HD; Milman T; Mruthyunjaya P; Simpson ER; Smith ME; Wilson DJ; Wirostko WJ; Harbour JW
    Ophthalmology; 2012 Aug; 119(8):1596-603. PubMed ID: 22521086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
    Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
    Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
    van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
    van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
    Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
    Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
    Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
    Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
    Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
    Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation of monosomy 3 status within uveal melanoma.
    Schoenfield L; Pettay J; Tubbs RR; Singh AD
    Arch Pathol Lab Med; 2009 Aug; 133(8):1219-22. PubMed ID: 19653713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
    Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.
    Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of monosomy 3 in uveal melanoma.
    Prescher G; Bornfeld N; Hirche H; Horsthemke B; Jöckel KH; Becher R
    Lancet; 1996 May; 347(9010):1222-5. PubMed ID: 8622452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.